Along with the well-established measures of T2D, such as fasting glucose and glucose tolerance tests, also non-glucose or insulin-related biomarkers for T2D exist, including low plasma adiponectin concentration that has been found to be a strong predictor for future T2D development [2,3]. This evidence concerns the gene INS and type 2 diabetes mellitus.